Health Care & Life Sciences » Pharmaceuticals | Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. | Income Statement

Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
641.00
2,456.00
2,449
Cost of Goods Sold (COGS) incl. D&A
5.40
6.00
4.00
490.00
187.00
80
Gross Income
5.40
6.00
4.00
151.00
2,269.00
2,529
SG&A Expense
4,298.50
6,328.00
7,428.00
10,161.00
13,040.00
16,056
EBIT
4,303.90
6,334.00
7,432.00
10,010.00
10,771.00
13,527
Unusual Expense
44.70
-
-
-
-
-
Non Operating Income/Expense
196.40
504.00
40.00
82.00
88.00
97
Interest Expense
-
-
9.00
11.00
6.00
6
Pretax Income
4,436.90
5,692.00
7,233.00
9,629.00
10,080.00
12,727
Income Tax
205.10
4.00
1.00
1,335.00
400.00
-
Consolidated Net Income
4,231.80
5,696.00
7,232.00
10,964.00
10,480.00
12,727
Net Income
4,231.80
5,696.00
7,232.00
10,964.00
10,480.00
12,727
Net Income After Extraordinaries
4,231.80
5,696.00
7,232.00
10,964.00
10,480.00
12,727
Net Income Available to Common
4,231.80
5,696.00
7,232.00
10,964.00
10,480.00
12,727
EPS (Basic)
0.59
0.62
0.67
0.87
0.79
0.86
Basic Shares Outstanding
7,209.30
9,244.10
10,820.50
12,624.40
13,309.40
14,882.40
EPS (Diluted)
0.59
0.62
0.67
0.87
0.79
0.86
Diluted Shares Outstanding
7,209.30
9,244.10
10,820.50
12,624.40
13,309.40
14,882.40
EBITDA
4,298.50
6,328.00
7,428.00
10,006.00
10,766.00
13,521
Non-Operating Interest Income
18.70
138.00
168.00
474.00
785.00
903

About Oramed Pharmaceuticals

View Profile
Address
Hi-Tech Park 2/4
Jerusalem JM 91390
Israel
Employees -
Website http://www.oramed.com
Updated 07/08/2019
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.